USE OF APPROVED DRUGS FOR UNLABELED INDICATIONS

被引:0
作者
不详
机构
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:544 / 544
页数:1
相关论文
共 50 条
[1]   UNLABELED USE OF APPROVED DRUGS [J].
SLY, RM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1983, 71 (05) :515-517
[2]   THE USE OF DRUGS FOR UNLABELED INDICATIONS [J].
ERICKSON, SH ;
BERGMAN, JJ ;
SCHNEEWEISS, R ;
CHERKIN, DC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 243 (15) :1543-1546
[3]   USE OF DRUGS FOR UNLABELED INDICATIONS [J].
NIGHTINGALE, SL .
AMERICAN FAMILY PHYSICIAN, 1986, 34 (03) :269-269
[4]   LEGAL IMPLICATIONS OF PREPARING AND DISPENSING APPROVED DRUGS FOR UNLABELED INDICATIONS [J].
PODELL, LB .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1983, 40 (01) :111-113
[5]   GAP BETWEEN APPROVED INDICATIONS AND USE OF OLDER DRUGS [J].
EADIE, MJ .
MEDICAL JOURNAL OF AUSTRALIA, 1993, 158 (09) :652-652
[6]   Report of the Council on Scientific Affairs: Unlabeled indications of Food and Drug Administration-approved drugs [J].
Cranston, JW ;
Williams, MA ;
Nielsen, NH ;
Bezman, RJ .
DRUG INFORMATION JOURNAL, 1998, 32 (04) :1049-1061
[7]   Report of the Council on Scientific Affairs: Unlabeled Indications of Food and Drug Administration-Approved Drugs [J].
Joseph W. Cranston ;
Michael A. Williams ;
Nancy H. Nielsen ;
Rebecca J. Bezman .
Drug information journal : DIJ / Drug Information Association, 1998, 32 (4) :1049-1061
[8]   The use of recently approved antiepileptic drugs: use with caution, use in refractory patients or use as first-line indications? [J].
Beghi, Ettore ;
Beghi, Massimiliano ;
Cornaggia, Cesare Maria .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (12) :1759-1767
[9]   Overall survival for oncology drugs approved for genomic indications [J].
Haslam, Alyson ;
Kim, Myung Sun ;
Prasad, Vinay .
EUROPEAN JOURNAL OF CANCER, 2022, 160 :175-179
[10]   SHORTAGES OF DRUGS WITH APPROVED ORPHAN INDICATIONS IN THE UNITED STATES [J].
Felemban, D. ;
Ghazawi, K. ;
Alsheikh, M. ;
Seoane-Vazquez, E. ;
Rodriguez-Monguio, R. ;
Fox, E. R. ;
Szeinbach, S. L. .
VALUE IN HEALTH, 2014, 17 (03) :A23-A23